Avanos Medical, Inc. (AVNS)
| Market Cap | 1.26B |
| Revenue (ttm) | 761.30M |
| Net Income (ttm) | 18.60M |
| Shares Out | 47.32M |
| EPS (ttm) | 0.39 |
| PE Ratio | 68.86 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 610,061 |
| Open | 26.16 |
| Previous Close | 25.83 |
| Day's Range | 25.84 - 26.65 |
| 52-Week Range | 24.54 - 38.92 |
| Beta | 0.87 |
| Analysts | Sell |
| Price Target | 39.27 (+47.7%) |
| Earnings Date | Aug 2, 2022 |
About AVNS
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for AVNS stock is "Sell." The 12-month stock price forecast is 39.27, which is an increase of 47.74% from the latest price.
News
Here's Why You Should Hold on to Avanos (AVNS) Stock For Now
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos Medical, Inc. to Present at the UBS 2022 Global Healthcare Conference
ALPHARETTA, Ga. , May 17, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present and participate in ...
Avanos Medical (AVNS) Q1 Earnings, Revenues Top Estimates
Avanos Medical's (AVNS) first-quarter 2022 results reflect strength in the Pain Management segment.
Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 8.33% and 0.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. Announces First Quarter 2022 Results
ALPHARETTA, Ga. , May 4, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2022 financial results.
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2022 Financial Results
ALPHARETTA, Ga. , April 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Wed...
Is Avanos Medical (AVNS) Stock Outpacing Its Medical Peers This Year?
Here is how Avanos Medical (AVNS) and Axcella Health Inc. (AXLA) have performed compared to their sector so far this year.
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum
ALPHARETTA, Ga., March 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial ...
New Strong Buy Stocks for March 11th
ABM, AVNS, ASIX, AA, and ESEA have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2022.
Does Avanos Medical (AVNS) Have the Potential to Rally 26% as Wall Street Analysts Expect?
The mean of analysts' price targets for Avanos Medical (AVNS) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ana...
Avanos Medical (AVNS) Q4 Earnings, Revenues Top Estimates
Avanos Medical's (AVNS) fourth-quarter 2021 results gain from strength in the chronic care segment.
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 15% and 1.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results
ALPHARETTA, Ga., Feb. 23, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2021 results.
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full yea...
Avanos Medical (AVNS) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 24th
AGNC, AVNS, and SQ have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2022
New Strong Sell Stocks for January 19th
ONEM, ALXO, and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 19, 2022
Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 10, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 40th Annual J.P.
Avanos Medical (AVNS) Set to Acquire OrthogenRx for $160M
Avanos Medical's (AVNS) deal to acquire OrthogenRx is likely to boost the company's chronic pain portfolio.
Avanos Medical, Inc. Announces Share Repurchase Authorization
ALPHARETTA, Ga., Dec. 15, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that its Board of Directors has approved a share repurchase program authorizing Avanos to purchase up to ...
Avanos Medical, Inc. Announces Agreement To Acquire OrthogenRx, Inc.
ALPHARETTA, Ga., Dec. 13, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire OrthogenRx, Inc., an emerging leader in viscosupple...
Avanos Medical's (AVNS) App to Support Pain Management Process
Avanos Medical's (AVNS) new solution to help healthcare providers with respect to patients' overall pain management process.
Avanos Medical (AVNS) Down 17.6% Since Last Earnings Report: Can It Rebound?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos Medical, Inc. Launches PainBlock Pro App
ALPHARETTA, Ga., Dec. 2, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its PainBlock Pro data collection and patient engagement app.
Avanos Medical (AVNS) Q3 Earnings Lag Estimates, Revenues Top
Avanos Medical's (AVNS) third-quarter 2021 results gains from strength in the Pain Management segment.